Zolmitriptan: Side Effects, Uses & Monitoring
Zolmitriptan tablets are indicated for the acute treatment of migraine with or without aura in adults.
- Data source
- FDA labeling via NIH DailyMed (label f6ca22bf…)
- Label version
- current
- Last reviewed
- 2026
Reported adverse reactions
Reactions listed in current FDA labeling, with the highest frequency reported across summarized placebo-controlled trials.
No structured frequency data available in current labeling. Consult the official label.
Labeled uses (from FDA prescribing information)
Zolmitriptan tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use: Only use zolmitriptan tablets if a clear diagnosis of migraine has been established. If a patient has no response to zolmitriptan tablets treatment for the first migraine attack, reconsider the diagnosis of migraine before zolmitriptan tablets are administered to treat any subsequent attacks. Zolmitriptan tablets are not indicated for the prevention of migraine attacks. Safety and effectiveness of zolmitriptan tablets have not been established for cluster headache.
Conditions associated with Zolmitriptan in labeling
Frequently Asked Questions
What is Zolmitriptan used for?
FDA labeling lists the approved uses shown above under "Labeled uses." This summary is informational; only a qualified prescriber can determine whether a medication is appropriate for you.
What are the most commonly reported side effects of Zolmitriptan?
Current labeling for this ingredient does not include a structured frequency table that we can reproduce. Review the official label linked below.
Does Zolmitriptan require lab monitoring?
Monitoring needs vary. Ask your healthcare provider whether any lab tests apply while taking Zolmitriptan.
Where does this information come from?
All clinical facts on this page were extracted from the current FDA-registered product labeling for this ingredient, published by manufacturers through NIH DailyMed. See the source link below.
Medical disclaimer: Educational content extracted from public FDA labeling. Not medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.